We are monitoring the impact of COVID-19 on Organ-on-Chip Market Get in touch with us for detailed analysis Know More
Pulished Date October, 2021
ID: 12347
Share on
Share on

Global Organ-on-Chip Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Application & Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Forecast (2021 to 2026)

Pulished: October, 2021
ID: 12347
Pages: 190

Global Organ-on-Chip Market Size (2021 to 2026)

The global organ-on-chip-market size is forecasted to be worth USD 284.65 million by 2026 from USD 60.29 million in 2021, registering a CAGR of 36.40% from 2021 to 2026.

An organ-on-a-chip (OOC) is a microfluidic cell culture device made with microchip manufacturing technologies that contain continuously perfused compartments populated by living cells and structured to mimic tissue and organ physiology. This chip creates a small channel for blood and air movement in organs like the lung, gut, liver, heart, and others. Using traditional 2D and 3D culture systems, such devices can develop different tissue and organ functionality levels. Organ-on-chip technology can be used for various purposes, including disease modeling, patient stratification, and phenotypic screening. Organs-on-chips, which simulate the physiology of human organs at the cellular level, is a viable alternative to animal models.

Impact of COVID-19 on the global organ-on-chip market:

Since the COVID-19 outbreak, the biopharmaceutical industry and the scientific community have become exceedingly proactive. As a result, Organ-on-chip has become one of the most adaptable technologies for generating medications and vaccines amid the pandemic. Simply put, the novel coronavirus has emerged as a profitable opportunity for the organ-on-a-chip sector, with constant growth expected during the forecast period.

MARKET DRIVERS:

Technological advancements and new product launches, a growing number of partnerships, and collaborations between pharmaceutical companies and organs-on-chips manufacturers are primarily promoting the global organ-on-chip market’s growth.

Researchers and scientists use Organ-on-chip culture systems to test the effects of various medications on the human body. Furthermore, this technology is used to analyze drug toxicity or effectiveness in various organs. The growing number of these processes is predicted to support the global organ-on-chip market. The ever-increasing focus on developing alternatives to animal testing models, a significant increase in research funding, and venture capital investments for the development of organs-on-chips are anticipated to boost the growth rate of the global organ-on-chip market. In addition, a growing need for early detection of drug toxicity to minimize financial risks is another significant factor driving the growth of this market.

Furthermore, with the healthcare sector increasing demand for advanced organ-on-chip technologies, it's expected that the market will continue to grow rapidly in the future years. Organ-on-chip technologies are primarily utilized for in-vitro biochemical analysis, real-time imaging, and metabolic and genetic activities of living cells in functional tissue. The continually expanding application breadth of OOCs is projected to drive demand for organs on chips during the forecast period. The growing prevalence of cardiovascular diseases (CVD) is likely to propel the organ-on-a-chip market to new heights. Organ-on-a-chip technologies were created to simulate the dynamic conditions of the circulatory system, particularly the heart and the general vasculature. Personalized medicine is a developing area that allows physicians to construct a targeted treatment for their patients, i.e., choosing the best possible medicines at the optimal dose depending on their specific needs. It has a massive opportunity for improving patient outcomes, especially in areas where a thorough grasp of each person's phenotypic and disease profile is critical. These patient-specific models aid in the prediction of toxicity and efficacy. Patients will be paired with the most appropriate medicines that will work for them in the future due to an emphasis on early disease identification and personalized medicine.

MARKET RESTRAINTS:

High production costs, as the costly redesigning process may be too much for the relatively tiny enterprises involved, may curb the organ-on-chip market growth.

Furthermore, developing bioreactors, pumps for perfusion of cell culture media, maintaining the cell environment, mechanical stimuli, and implementing cell analysis methods are difficult and expensive. Manufacturers of organs-on-chips are increasingly turning to big data to deal with the data created by OOCs. The data generated by OOCs can face several challenges, including sharing, integrating, and evaluating it. In addition, big data methods must be implemented on modern high-performance computing platforms to use the created data properly.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Type, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

 

This research report on the global organ-on-chip market has been segmented and sub-segmented based on type, application, and region.

Organ-on-chip market – By Type:

  • Heart-on-chip
  • Human-on-chip
  • Intestine-on-chip
  • Kidney-on-chip
  • Liver-on-chip
  • Lung-on-chip

Based on type, the lung-on-chip dominated the global organ-on-chip market in 2020 and is predicted to continue the same trend during the forecast period. Lung-on-chip technology is a complicated three-dimensional replica of a living, breathing human lung. This technology, which comprises human lung and blood vessel cells, can predict nanoparticle absorption and stimulate the inflammatory response induced by microbial infections. The device can also assess environmental contaminants, aerosolized treatments absorption, and the safety and efficacy of novel medications. Thus, it is anticipated that it will become a viable alternative to animal testing.

Organ-on-chip Market – By Application:

  • Drug Discovery
  • Toxicology Research
  • Other Applications

Drug discovery is expected to be the most popular segment, accounting for the largest share of the global market. As a result, pharmaceutical companies use OOCs widely for drug discovery and clinical trials in various chronic treatment areas.

Organ-on-chip Market – By Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

Geographically, North America is predicted to have the most significant share of the global organ-on-chip market and grow at the fastest CAGR. Because of the vast availability of extensive lines of services given by prominent organizations and the spike in chemicals' toxicity testing on various organ cells, America has emerged as the organ-on-chip market leader. In addition, private and public institutes invest a lot of money in extensive research, which adds to the region's market value.

Europe was ranked second worldwide in 2020 and is expected is accelerate at a prominent growth rate. The European market benefits from establishing multiple reputable OOC developers across Germany, the United Kingdom, Italy, Spain, and France, as well as government efforts and financing for research operations. Increased cooperation between corporations, institutes, and universities for the creation of higher-quality OOCs and the availability of well-established healthcare infrastructure are estimated to help the market grow in the next few years.

Due to the lucrative opportunities presented by nations like China, India, and Japan, Asia-Pacific is predicted to develop the fastest over the projection period. Furthermore, as the population's disposable income rises, the region's adoption of Organ-on-a-Chip technology is likely to increase. The expansion of the Organ-on-a-Chip market in the Asia-Pacific region is predicted to be supported by government support for regenerative medicines in research institutions and an increase in the number of cell-based clinical trials and investment in R&D activities.

KEY MARKET PARTICIPANTS:

Emulate, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, TissUse, Hesperos, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, and Else Kooi Laboratory are some of the noteworthy companies operating in the global organ-on-chip market profiled in this report.

RECENT MARKET DEVELOPMENTS:

  • CN Bio, a famous creator of innovative single and multi-organ microphysiological systems or organ-on-a-chip, announced the release of their new PhysioMimix OOC Multi-Organ MPS in March 2021.
  • In 2020, CN Bio and Imperial College London will collaborate to use CN Bio's liver-on-chip technology to help researchers better understand the underlying mechanisms of alcoholic hepatitis and identify new therapeutic targets.
  • The license agreement for InSphero's Akura Flow organ-on-a-chip platform was announced in 2020 by InSphero AG and ETH Bio Engineering Laboratory.
  1. Introduction
    1. Market Definition
    2. Scope of the report
    3. Study Assumptions
    4. Base Currency, Base Year and Forecast Periods
  2. Research Methodology
    1. Analysis Design
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Data Modelling
      4. Expert Validation
    3. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking
      1. Market share analysis
      2. Products/Service
      3. Regional Presence
    2. Mergers & Acquisition Landscape
    3. Joint Ventures & Collaborations
  6. Market Segmentation 
    1. Organ-on-chip market, By Type
      1. Heart-on-chip
      2. Human-on-chip
      3. Intestine-on-chip
      4. Kidney-on-chip
      5. Liver-on-chip
      6. Lung-on-chip
      7. Market Size Estimations & Forecasts (2021-2026)
      8. Y-o-Y Growth Rate Analysis
      9. Market Attractiveness Index         
    2.  Organ-on-chip market, By Application
      1. Drug Discovery
      2. Toxicology Research
      3. Other Applications
      4. Market Size Estimations & Forecasts (2021-2026)
      5. Y-o-Y Growth Rate Analysis
      6. Market Attractiveness Index
  7. Geographical Landscape
    1. Global Organ-on-chip market, By Region
    2. North America - Market Analysis (2021 to 2026)
      1. By Country
        1. USA
        2. Canada
    3. Europe
      1. By Country
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
    4. Asia Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. South East Asia
        6. Australia & NZ
        7. Rest of Asia-Pacific
    5. Latin America
      1. By Country
        1. Brazil
        2. Argentina
        3. Mexico
        4. Rest of Latin America
    6. Middle East and Africa
      1. By Country
        1. Middle East
        2. Africa
  8. Key Player Analysis
    1. Emulate
      1. Business Description
      2. Products/Service
      3. Financials
      4. SWOT Analysis
      5. Recent Developments
      6. Analyst Overview
    2. CN Bio Innovations
    3. Tara Biosystems
    4. Draper Laboratory
    5. Mimetas
    6. TissUse
    7. Hesperos
    8. Nortis
    9. Micronit Microtechnologies B.V.
    10. Kirkstall
    11. Cherry Biotech SAS
    12. Else Kooi Laboratory
  9. Market Outlook & Investment Opportunities
  10. Appendix
    1. List of Tables
    2. List of Figures
  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of service and industry verticals along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Global Organ on a chip Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  3. Global Heart-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global  Human-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Intestine-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global Kidney-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Liver-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Lung-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  10. Global Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global  Toxicology Research Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  13. North America Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  14. North America Heart-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  15. North America  Human-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  16. North America Intestine-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  17. North America Kidney-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  18. North America Liver-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  19. North America Lung-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  20. North America Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  21. North America Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America  Toxicology Research Market, By Region, From 2021 to 2026 (USD Billion)
  23. North America Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  24. United States Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  25. United States Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  26. Canada Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  27. Canada Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  28. Europe Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  29. Europe Heart-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  30. Europe  Human-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  31. Europe Intestine-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  32. Europe Kidney-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  33. Europe Liver-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  34. Europe Lung-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  35. Europe Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  36. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  37. Europe  Toxicology Research Market, By Region, From 2021 to 2026 (USD Billion)
  38. Europe Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  39. U.K. Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  40. U.K. Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  41. Germany Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  42. Germany Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  43. France Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  44. France Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  45. Italy Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  46. Italy Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  47. Spain Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  48. Spain Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  49. Asia Pacific Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  50. Asia Pacific Heart-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  51. Asia Pacific  Human-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  52. Asia Pacific Intestine-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  53. Asia Pacific Kidney-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  54. Asia Pacific Liver-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  55. Asia Pacific Lung-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  56. Asia Pacific Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  57. Asia Pacific Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  58. Asia Pacific  Toxicology Research Market, By Region, From 2021 to 2026 (USD Billion)
  59. Asia Pacific Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  60. Japan Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  61. Japan Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  62. China Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  63. China Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  64. India Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  65. India Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  66. Australia Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  67. Australia Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  68. South Korea Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  69. South Korea Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  70. Latin America Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  71. Latin America Heart-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  72. Latin America  Human-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  73. Latin America Intestine-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  74. Latin America Kidney-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  75. Latin America Liver-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  76. Latin America Lung-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  77. Latin America Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  78. Latin America Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  79. Latin America  Toxicology Research Market, By Region, From 2021 to 2026 (USD Billion)
  80. Latin America Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  81. Brazil Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  82. Brazil Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  83. Argentina Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  84. Argentina Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  85. Mexico Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  86. Mexico Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  87. Rest of Latin America Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  88. Rest of Latin America Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  89. Middle East and Africa Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  90. Middle East and Africa Heart-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  91. Middle East and Africa Human-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  92. Middle East and Africa Intestine-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  93. Middle East and Africa Kidney-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  94. Middle East and Africa Liver-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  95. Middle East and Africa Lung-on-chip Market, By Region, From 2021 to 2026 (USD Billion)
  96. Middle East and Africa Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  97. Middle East and Africa Drug Discovery Market, By Region, From 2021 to 2026 (USD Billion)
  98. Middle East and Africa Toxicology Research Market, By Region, From 2021 to 2026 (USD Billion)
  99. Middle East and Africa Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  100. Middle East Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  101. Middle East Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)
  102. Africa Organ on a chip Market, By Type, From 2021 to 2026 (USD Billion)
  103. Africa Organ on a chip Market, By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample